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Aims: The objective of the study was to examine if depression or anxiety was associated with youth 
cannabis use; and investigate whether flourishing moderates these associations. 
 
Methods: Students (N=8179) were recruited from 10 secondary schools (grade 9-12) in Ontario and 
British Columbia, Canada Self-report questionnaires were used to assess symptoms of depression [CESD-
R-10], anxiety [GAD-7], flourishing [Deiner’s Flourishing Scale] and cannabis consumption using 
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interactions were used to examine the associations between mental health and youth cannabis use, and 
the potential moderating effect(s) of flourishing.  
 
Results: In our sample, 33% of participants had ever used cannabis, 51% and 38% reported elevated 
depressive and anxiety symptoms, respectively. Associations between depression, anxiety, and cannabis 
use were no longer significant when flourishing was added to the models. In addition, there was no 
evidence suggesting a moderating effect of flourishing as all interactions were not statistically 
significant. Instead, robust associations were found between flourishing and cannabis use : mental 
health and cannabis ever use, mental health and cannabis use frequency.  
 
Conclusions: Indicators of mental wellbeing, such as flourishing, appear to be associated with a lower 
likelihood of cannabis use, even after controlling for depression and anxiety.  Results suggest prevention 
strategies for youth cannabis use should aim to foster mental wellbeing among all youth, rather than 
exclusively targeting those experiencing mental health problems. Future longitudinal studies should test 
the sequential relationship between cannabis use and changes in both positive and negative mental 
health.  
  



















Nearly 1 in 4 Canadian youth aged 15 and 17 years have experimented with cannabis at least once in 
their lifetime, making cannabis the most widely used illicit drug by young Canadians (1). The 
Government of Canada has initiated the process to legalize cannabis leading many to express concerns 
pertaining to new regulations and the impact this may have on youth development (2). Despite the 
minimum age to purchase cannabis under the federal law has been determined as 18 years, research 
has demonstrated that a temporary increase in use among youth populations is probable (3–5).  
 
While negative repercussions associated with cannabis can occur at any age, youth are at an increased 
risk as the brain is exceptionally susceptible to adverse effects during this stage of development (6–9). 
Youth are at a disproportionate risk for addiction (10), developing a cannabis use disorder (11), and 
impaired reckless driving with fatal outcomes (12–14). One of the leading concerns has been the 
association between cannabis use and mental health. Research shows that the risk of developing 
substance use disorders is doubled in people with mental illnesses compared to the general population, 
and at least 20% of people with a mental illness have a co-existing substance use problem (15). 
Moreover, frequent cannabis exposure at a young age is correlated with an increased risk and earlier 
onset of mental illness (16–19). Patton and colleagues (16) identified a dose-response relationship 
where frequency of cannabis use predicted later depression and anxiety in adolescent girls, with daily 
use presenting the highest risk. Prior to the legislation surrounding cannabis being enacted, important 
questions remain about current cannabis use among Canadian youth and the correlation to other 
common health-related concerns. Of particular concern to public health professionals, is the link 
between cannabis use and mental illnesses, specifically depression and anxiety.   
 
Available literature has highlighted a presumable association where cannabis users have been found to 
experience poorer mental health (16,20–23), however, there is limited knowledge related to the 
patterns and frequency of youth cannabis use and possible factors associated with initial uptake. 
Moreover, critical research gaps remain in how positive aspects of wellbeing, such as flourishing or 
resilience, may co-exist and serve as a protective measure against the use of cannabis in high-risk 
populations. Flourishing is defined as the presence of positive mental health inclusive of emotional, 
psychological and social prosperity and is a good indicator overall wellbeing (24–26). A greater 
understanding of how mental health and aspects of wellbeing are correlated wi th youth cannabis use is 
warranted to inform future prevention strategies, and in turn, minimize latent health consequences that 
may accompany the legalization of cannabis in Canada. While there is currently limited research 
examining the association between mental health and cannabis use  in youth, this has been identified 
more recently as a leading public health concern made evident by new federal investments  providing 
the Mental Health Commission of Canada and the Canadian Centre on Substance Use and Addition  with 
funding budgets to explore this relationship. 
 
Developing a more robust understanding of the associations between youth cannabis use and mental 
health would be valuable in helping to inform the pending legalization of cannabis in Canada. This 
manuscript will examine the association between mental health and cannabis use among youth using 
the pilot data from the Mental Health Module (MH-M) of the COMPASS study. Specifically, we aim to 
examine if depression or anxiety symptoms are associated with cannabis use among secondary school 
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The COMPASS Study (COMPASS) is a longitudinal, prospective cohort study (2012-2021) that collects 
data from students in grades 9 to 12 attending participating secondary schools across Canada (27). 
During the COMPASS year 5 (Y5[2016-2017]) data collection, a new module was included to measure 
student mental health, given that schools participating in the earlier waves of COMPASS identified this 
as a priority area that was missing from the survey tools. As such, this paper uses the new student-level 
data collected from students attending 10 COMPASS schools who participated in the MH-M pilot. In this 
pilot, the only change to the study protocol was that the student questionnaire incl uded eight new 
additional subsections about youth mental health as a supplement within the original student 
questionnaire (27). A complete description of COMPASS methods is available in print (27) or online 
(www.compass.uwaterloo.ca). Researchers may access COMPASS data by completing an online 
application form (https://uwaterloo.ca/compass-system/information-researchers). COMPASS received 




Data were collected from 8,179 students attending selected secondary schools in British Columbia (N=5) 
and Ontario (N=9), Canada. Specific schools were recruited to participate in the pilot stage of the mental 
health module during year 5 of the COMPASS data collection based on expressed interests in the mental 
health data. This recruiting strategy allowed for a diversified population and comparisons across 
jurisdictions. Students were recruited using an active-information passive-consent protocol (27),  a 
strategy shown to be important for collecting robust data on self-reported risk behaviours such as 
substance use among youth (28–31). A complete-case analysis was used for this manuscript and a total  
of 8,040 students were included in the analysis.  
 
Measures 
Outcome variable - Cannabis use 
Consistent with previous research (32), cannabis use was assessed by asking students “In the last 12 
months, how often did you use marijuana or cannabis? (a joint, pot, weed, hash)”. Binary outcome 
responses were recoded into “never users” if the student had never used cannabis, and all other 
responses were coded as “ever users”. For ordinal responses, cannabis use frequency was recoded into 
“never,” if students had never used cannabis, “rare/sporadic” if respondents used cannabis less than 
once a month, “monthly” if reported use was once to 3 times per month, “weekly” if use ranged from 1 
to 3 times a week, “habitual” if reported use was 4 to 6 times a week, and “daily”.   
 
Explanatory variable - Depressive and anxiety symptoms  
Youth depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale 
(Revised)-10 (CESD-R10; (33)). This scale was designed to assess self-reported symptoms of depression 
by asking respondents about feelings of sadness, loss of interest, and difficulties sleeping, making 
decisions and concentrating over a 1-week period, and has been validated in both adolescent and adult 
populations (33–35). Internal consistency of the CESD-R-10 scale was high (α= 0.983). Symptoms of 
anxiety were measured using the Generalized Anxiety Disorder 7-item Scale (GAD-7; (36)). The GAD-7 
reports on self-perceived feelings of worry, fear, and irritability over a 2-week period of time and has 
been validated for youth populations. The GAD-7 had an alpha coefficient of 0.986. The CESD-R-10 and 
GAD-7 scales were fit as categorical variables for each model. Consistent with other research, this study 












  Mental Health and Youth Cannabis Use 
5 
 
problems and applied a binary coding system to categorize students with and without clinically relevant 
symptoms (control=0, depression and/or anxiety=1).  
 
Moderating variable- Flourishing 
Levels of psychosocial prosperity and wellbeing among students was measured using Diener’s 
Flourishing Scale (FS; (25)). This scale assessed how respondents perceived their relationships, life 
purpose and satisfaction, engagement and interest with daily activities, self-esteem and competence, 
and optimism to provide a score that represents overall psychological wellbeing, or flourishing.  To 
maintain suitability for large school-based studies among youth and consistency with other questions in 
the COMPASS MH-M (37), the original 7-point Likert scale was reduced to a 5-point response option 
with total scores ranging from 8 to 40. The FS measures wellbeing on a flourishing-languishing 
continuum and all item statements are positively framed (25). To remain consistent with the other 
mental health measures used in this study, where higher scores indicated greater symptoms of mental 
health problems, the FS was reverse coded and high scores represent languishing (poor wellbeing). 
 
Covariates 
Covariates were included to reduce potential confounding and are as follows: Grade (9, 10, 11, 12); sex 
(female, male); ethnicity (White, Black, Asian, Aboriginal [First Nations, Métis, Inuit], Latin American or 
Hispanic, Mixed/Other); weekly spending money ($0, $1-$20, $21-$100, more than $100, I don’t know); 
truancy (no skipped classes, 1 or more missed classes per week), binge drinking (non-current binge 
drinker, current binge drinker [reported consuming 5 or more alcoholic beverages in the past month]) 




All analyses were conducted in SAS 9.4. Ever use of cannabis (dichotomous dependent variable) was fit 
using logistic models and cannabis use frequency (ordinal dependent variable) was fit using ordinal 
logistic regression models. The explanatory variables were fit as dichotomous variables using the 
predetermined thresholds that are used to classify clinically relevant symptoms of depression and 
anxiety. To help with the interpretation of the results, we used a stepwise modeling approach: 1) the 
main effects of depression and anxiety were tested, 2) flourishing was added and main effects tested, 
and 3) inclusion of 2-way and 3-way interactions among depression, anxiety, and flourishing to test for 
moderation. Using a stepwise modeling approach, we were able to demonstrate and evaluate significant 
changes and interactions after including each variable. In addition to the 6 logistic models reported on, 
depression and anxiety variables were separately fit as continuous variables in these models to 
triangulate our results.  
 
RESULTS  
Sample Characteristics  
Demographic characteristics for the total sample (n=8,040) can be found in Table 1. Among participating 
students, 33% reported ever using cannabis, and 7% were daily users. Depression and anxiety (scores ≥ 
10) was reported by 51% and 38% of students, respectively, and showed increased prevalence in older 
grades. As shown in Figure 1 and Figure 2, the same trend was demonstrated for continuous measures 
of depression and anxiety for grade level. Consistent with available literature (38), co-occurring mental 
health problems were common, as 86% of students reporting depression also reported having anxiety. 
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majority of the sample reported their ethnicity as White (71.0%), and 50.8% were female. Descriptive 
results stratified by sex (Table 1) demonstrate female cannabis use was more likely to be sporadic and 
monthly, while male cannabis use was more likely to be weekly, habitual or daily. Additionally, females 
were more apt to report depression, anxiety, and lower flourishing levels compared to males.  
 
As shown in Table 2, cannabis ever use was lowest among grade 9 students (14.4%), and the prevalence 
nearly doubled in grade 10 students (27.9%). A similar trend was observed for all frequency levels (Table 
3). Compared to never users, cannabis ever users were more likely to smoke  (29.4% vs 1.8%), binge 
drink (75.5% vs 18.1%), be depressed (61.0% vs 46.2%), be anxious (46.1% vs 34.1%), and report lower 
flourishing scores (17.9 vs 16.0). The frequency of clinically relevant symptoms of depression and 
anxiety, current smoking, and current binge drinking, was higher with more frequent cannabis use. 
Moreover, daily users had the highest frequency of depressive (72.9%) and anxiety (60.4%) symptoms, 
current smoking (65.9%), current binge drinking (87.3%), and reported the poorest flourishing scores 
(20.8).   
 
Main Effects and Interactions 
Results for the comprehensive models that included all interaction terms (model 3 and model 6) are 
shown in Table 4 and Table 5. For all comprehensive models, flourishing was the only variable associated 
with cannabis ever use and frequency of use, whereby increases on the flourishing-languishing 
continuum (higher scores reflect languishing) were associated with more frequent cannabis use. As seen 
in Table 4, for every one-unit increase on the flourishing scale, the likelihood of cannabis ever use 
increases B=0.040, SE=0.012,  p≤0.01. Whereas depression was found to be associated with cannabis 
ever use (B=0.281, SE=0.078, p≤0.01) in model 1, neither depression nor anxiety were significantly 
associated with cannabis ever use after including flourishing in model 2 and 3. Table 5 demonstrates 
that for that for every unit increase on the flourishing scale, the likelihood of cannabis use frequency 
increases B=0.042, SE=0.010, p<0.001. While depression (B=0.287, SE=0.068, p<0.001) and anxiety 
(B=0.239, SE=0.068, p≤0.01) were found to be associated with cannabis ever use in model 4, neither 
were associated with the frequency of cannabis use after including flourishing in model 5 and 6. 
Moreover, after including flourishing in the final models, there were no significant 2-way or 3-way 
interactions identified in our complete analysis. The 6 models yielded concordance statistic ranging 
between 0.852-0.881, suggesting all models within our analysis were a good fit. As expected, binge 
drinking, smoking and truancy were significantly associated with an increased risk of cannabis use in all 
models. Triangulation of the models, using continuous depression and anxiety explanatory variables, 
confirmed our expectations and results were consistent with the binary models in that depression and 
anxiety were no longer significantly associated after including flourishing in the models  and there were 
no significant interactions. As these results were primarily used to validate our results, they are not 
presented throughout this manuscript.  
 
DISCUSSION 
Cannabis use and mental health in Canadian youth  
This study examined the association between mental health and cannabis use within secondary school 
students in Ontario and British Columbia, Canada. Overall, cannabis use and depressive and anxiety 
symptoms were common among youth. Half of the students in our study scored above the accepted 
threshold for depression and over one third for anxiety. Results demonstrate that depression, anxiety, 
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likely to experience depression and anxiety (39), and the majority of youth with depression had co-
occurring anxiety (40,41). Co-occurring depression and anxiety have been identified to be highly 
prevalent in adolescent substance users and are typically more severe and problematic (40,42,43). 
Additionally, one third of the students in our study had tried cannabis at least once and nearly 10% 
indicated using cannabis at least once a week. Consistent with previous research, youth who use 
cannabis were substantially more likely to engage in alcohol and tobacco use (44). On average, cannabis 
users in our study were upwards of 10 times more likely to smoke and 7 times more likely to binge drink. 
The frequency of cannabis use was directly related to these risk factors, by which daily cannabis users 
were the most likely report smoking and/or binge drinking compared to all other levels of frequencies 
measured. Our findings align with other research (43) that suggests adolescence is the peak age for 
cannabis uptake as we observed a significant increase in cannabis ever use between grade 9 and grade 
12 and found that older students used cannabis at higher frequencies. Descriptive analysis identified the 
largest increase in depression, anxiety and cannabis use within grade 10 students, suggesting this may 
be critical period for interventions and prevention strategies. 
 
Research Implications 
Findings of this study are particularly novel in which it identified that flourishing appears to mitigate 
potential negative associations between depression and/or anxiety and youth cannabis use. This has not 
yet been demonstrated previously in the literature, and  most evidence suggests there is a link between 
depression, anxiety and cannabis use (16,45–47). Although we did find depression and anxiety to be 
significantly correlated with cannabis use in some of our analyses, our stepwise modelling approach 
helped illustrate that these associations were no longer significant after including flourishing within our 
models. Our results suggest that higher flourishing may result in lower cannabis use regardless of having 
high depression or anxiety symptoms. While findings from this study are preliminary, they fill a crucial 
knowledge gap within research, practice, and clinical domains and may present significant implications 
for innovative and universal prevention approaches using indicators of mental wellbeing to reduce 
youth substance use.  
 
This study focused on exploring flourishing as a moderator. While this was not evident, our results 
suggest that flourishing acts as a dominant confounding variable in the association between depression 
and anxiety, and cannabis use. We are unaware of any research that has controlled for mental wellbeing 
when exploring this association, and therefore, available evidence may not represent accurate findings 
between cannabis use and depression and anxiety. Future research and large surveillance tools should 
aim to measure and control for positive mental health given its large confounding effects. Lastly, 
longitudinal research is required to inform the temporal sequence and the direction of effect between 
mental health and cannabis use. Considering COMPASS has now incorporated the MH-M in all data 
collections in wave 6 (Y6[2017-2018]), it will soon be possible for future COMPASS studies to examine 
the relationship between depression, anxiety, and cannabis use and the role of flourishing over time 
once longitudinal mental health data become available. Consistent with this study, additional analysis 
will also be conducted to see if flourishing has a similar effect in other substance use  domains including 
tobacco and alcohol. As cannabis use has been found to increase with age (3,48), reproducing this study 
in young adults may also provide valuable insight for prevention and intervention programs that are 
targeted at an older population, such as university and college students. 
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Flourishing appears to be protective against substance use for all youth regardless of depression or 
anxiety symptoms. Consistent with more recent literature (49–51) this suggests that a universal 
approach to fostering mental wellbeing and building resilience among all youth in schools should be a 
leading priority and may be more effective at reducing substance use rather than intervention strategies 
targeting individuals with mental illness. A systematic review of universal, school-based substance use 
interventions, demonstrated that intervention type and approach as well as setting is important for 
long-term effects (52). Interventions were most effective when programs addressed resilient-protective 
factors as part of a multidimensional intervention approach that targeted broader individual resilience 
factors (e.g., social, emotional and cognitive competencies, self efficacy and regulation, academic 
achievement) as well as environmental resilience factors (e.g., school connectedness, community 
participation and support, parent support and involvement) (52). The same long-term effects were seen 
in universal-only approaches as well as interventions that were implemented within a school setting 
(52).  As abstinence-focused interventions targeting substance use have been shown to be ineffective 
(53,54), it is crucial to consider prevention programs that do not inherently target substance use, rather 
upstream factors such as flourishing and resilience, that contribute to overall wellbeing. Researchers 
expect cannabis uptake in Canadian youth to follow a similar trajectory to what has been observed in 
other jurisdictions (e.g. Colorado, Washington State) that have legalized cannabis (3–5). Longitudinal 
research examining how flourishing is related to different substance use trajectories will produce 
valuable prevention planning insight moving forward. 
 
Clinical Implications  
Our results demonstrate the importance of fostering good mental wellbeing to mitigate the use and 
misuse of cannabis in secondary school students. There would be great value in replicating this study on 
other substance use outcomes, and using clinical-based data that uses true diagnostic criteria for mental 
disorders. Personality-targeted interventions have also shown to be effective at reducing cannabis use 
within high-risk adolescents (55). A study conducted in the UK secondary schools found that targeted-
interventions that provide personality-specific coping skills relative to the individual, resulted in 
significant reductions of cannabis use in high-risk youth after a 2-year follow-up (55). Prevention-
intervention approaches used within this study included sessions that promoted positive coping 
behaviours and goal-setting, as well as evaluating cognitive-behavioural components. Given the 
resources and training that were required for school staff, this approach may be more appropriately 
implemented at the clinical level. Research should continue to reference previous studies that have 
explored domains similar to flourishing such as resilience, coping, and other domains of psychosocial 
wellbeing to inform future substance use prevention strategies.  
 
Strengths and Limitations  
This study is not without limitations. Foremost, our results were cross-sectional, and as such, causality 
and temporality of our findings cannot be inferred. However, given the nature of the pilot study, an 
initial cross-sectional analysis was warranted to evaluate the prevalence of mental health problems and 
inform future longitudinal studies using data from the COMPASS MH-M. Secondly, all measures included 
in our analyses were self-reported and are subject to social desirability bias and recall bias. The biases 
mentioned allow for potential misclassification of both the exposure and outcome and could lead to our 
results underestimating the association between depression, anxiety, flourishing and cannabis use in 
youth. Moreover, by employing a complete-case analysis, our results may underestimate the true 
association as unreported/missing data may be more likely among students with mental health 
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scales and not diagnostic criteria. While self-reported data does come with limitations, COMPASS 
ensures confidentiality of data through autotomized student surveys and utilizes a passive consent 
protocol to reduce the effects of information bias (social desirability and recall bias) and missing data. If 
available, future analyses might consider including additional measures such as parental factors, risk 
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Table 1. Sample Descriptive by Sex* 
 
*Complete case analysis only. Students with missing data for sex, grade and cannabis use were removed 
from analysis  
** Higher scores are indicative of higher languishing/lower flourishing (FS scores range from 8-40) 
***Numbers may not add to total sample due to missing data  






































Province  Ontario 



















26.4 (1038)  
23.3 (917)  
21.6 (847)  
11.1 (437)  
64.18,  <0.001 
Truancy  No skipped class  













Binge Drinking Non-binge drinker 













Anxiety (GAD-7) No Anxiety  






Flourishing (FS) ** 
 





Cannabis Ever Use Never Use 




 32.7 (1293) 
0.05,  0.83 
Cannabis Use *** Never Use 
Sporadic/Rare Use   
Monthly Use 
Weekly Use 
Habitual use  
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Table 3. Sample Descriptive by Frequency of Cannabis Use 
 





































































































Province  Ontario 
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Flourishing (FS) (8-40) ANOVA 
Mean (SD) 
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Table 4. Cannabis Ever Use for grade 9-12 students in year 5 of the mental health pilot of COMPASS 
(using depression and anxiety threshold measures) 
 





and Flourishing  
Model 3 
2-way and 3-way 
interactions (final 
model) 







































































Truancy  No skipped class  















Binge Drinking  Non-binge drinker 







Main Effects  B(SE) B(SE) B(SE) 
Depression (Dep) No Depression 
Depression (≥10) 
 





Anxiety (Anx) No Anxiety  









  0.033 (0.007)** 0.040 (0.012)* 
Interactions    B(SE) 
Dep*Anx     1.297 (0.628) 
Dep*Flourish    0.009 (0.019) 
Anx*Flourish    0.031 (0.033) 
Dep*Anx*Flourish    -0.065 (0.038) 
 Concordance statistic  0.881 0.880 0.881 
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Table 5. Frequency of Cannabis Use for grade 9-12 students in year 5 of the mental health pilot of 
COMPASS (using depressive and anxiety threshold measures) 
 





and Flourishing  
Model 6 
2-way and 3-way 
interactions (final 
model) 







































































Truancy  No skipped class  















Binge Drinking  Non-binge drinker 







Main Effects  B(SE) B(SE) B(SE) 


















  0.039 (0.005)** 0.042 (0.010)** 
Interactions    B(SE) 
Dep*Anx     0.649 (0.536) 
Dep*Flourish    -0.004 (0.016) 
Anx*Flourish    0.028 (0.028) 
Dep*Anx*Flourish    -0.032 (0.032) 
 Concordance statistic  0.852 0.853 0.854 
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 Youth cannabis users commonly indicated mental health problems 
 Depression and anxiety were not associated with cannabis use  
 Flourishing was associated with a lower likelihood of overall youth cannabis use  
ACCEPTED MANUSCRIPT
